Share chart Jasper Therapeutics, Inc.
Extended chart
Simple chart
About Jasper Therapeutics, Inc.
Jasper Therapeutics, Inc., биотехнологическая компания клинической стадии, разрабатывает терапевтические агенты для трансплантации гемопоэтических стволовых клеток и генной терапии. Основное внимание уделяется разработке и коммерциализации терапевтических средств для лечения таких заболеваний, как хроническая спонтанная крапивница, миелодиспластический синдром с низким и средним риском, а также новых режимов кондиционирования для трансплантации стволовых клеток и генной терапии ex-vivo, метода, в котором генетические манипуляции с клетками проводится вне тела перед трансплантацией. more detailsIPO date | 2021-09-24 |
---|---|
ISIN | US4718711033 |
Industry | Biotechnology |
Sector | Health Care |
Валюта | usd |
Валюта отчета | usd |
Сайт | https://www.jaspertherapeutics.com/ |
Цена ао | 5.8 |
Change price per day: | 0% (5.8) |
---|---|
Change price per week: | -5.84% (6.16) |
Change price per month: | +0.346% (5.78) |
Change price per 3 month: | -75.04% (23.24) |
Change price per half year: | -73.39% (21.8) |
Change price per year: | -72.71% (21.25) |
Change price per 3 year: | +55.91% (3.72) |
Change price per 5 year: | -41.24% (9.87) |
Change price per 10 year: | 0% (5.8) |
Change price per year to date: | -72.87% (21.38) |
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
Institutions | Volume | Share, % |
---|---|---|
Velan Capital Investment Management LP | 1121904 | 1.01 |
BVF Inc. | 990000 | 0.89 |
Carlyle Group Inc. | 876189 | 0.79 |
Qiming U.s. Ventures Management, Llc | 851965 | 0.76 |
Soleus Capital Management, L.P. | 830098 | 0.74 |
Sphera Funds Management Ltd. | 568713 | 0.51 |
Fernwood Investment Management, LLC | 494706 | 0.44 |
Franklin Resources, Inc. | 450022 | 0.4 |
Octagon Capital Advisors LP | 446811 | 0.4 |
Vanguard Group Inc | 379296 | 0.34 |
ETF | Share, % | Profitability for 1 year, % | Dividends, % |
---|---|---|---|
iShares Micro-Cap ETF | 0.06858 | 17.09 | 1.54048 |
![]() |
0.01994 | 38.04 | 0.6026 |
0.04 | 27.57 | 1.07 |
Head | Job title | Payment | Year of birth |
---|---|---|---|
Mr. Ronald A. Martell | President, CEO & Director | 892.45k | 1962 (63 years) |
Dr. Judith Anne Shizuru M.D., Ph.D. | Co-Founder & Director | 291.25k | 1957 (68 years) |
Mr. Jeetinder Singh Mahal M.B.A. | Chief Operating Officer | 579.46k | 1973 (52 years) |
Dr. Luca Di Noto Ph.D. | Senior Vice President of Technical Operations | N/A | |
Mr. David Ku M.D. | Vice President of Corporate Development, Portfolio Strategy & Management | N/A | |
Mr. Matthew Ford | Vice President of Human Resources | N/A | |
Dr. Wendy Pang M.D., Ph.D. | Senior Vice President of Research & Translational Medicine | N/A | |
Dr. Edwin Jonathan Tucker M.D. | Chief Medical Officer | N/A | 1972 (53 years) |
Mr. Herbert C. Cross | CFO & Corporate Secretary | N/A | 1972 (53 years) |
Ms. Patricia Carlos | Senior Vice President of Regulatory Affairs & Quality | N/A |
Address: United States, Redwood City. CA, 2200 Bridge Pkwy - open in Google maps, open in Yandex maps
Website: https://www.jaspertherapeutics.com/
Website: https://www.jaspertherapeutics.com/